Christina Ornauer

Christina Ornauer has held various roles in the healthcare industry since 2001. Christina began their career at Sandoz as a Medical Manager and Manager Clinical Operations in 2001. In 2004, they moved to Novartis as a Medical Advisor. In 2007, they joined Amgen GmbH as a Medical Leader. In 2008, they were appointed Medical Director at Celgene GmbH. In 2020, they took on the role of Medical Director at Takeda Pharma GesmbH. Most recently, in 2021, they were a Healthcare Executive and is currently the Chief Medical Officer at Bloom Diagnostics.

Christina Ornauer obtained their Doctor's Degree in Medicine from the Medical University of Vienna in 2001. In 2021, they earned a certification in Adaptability & Resilience from McKinsey & Company.